VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $651,000 | +70.9% | 58,983 | +125.0% | 0.01% | +150.0% |
| Q4 2016 | $381,000 | -3.5% | 26,216 | +1083.6% | 0.00% | 0.0% |
| Q3 2015 | $395,000 | +23.1% | 2,215 | +53.2% | 0.00% | +100.0% |
| Q2 2015 | $321,000 | -87.5% | 1,446 | -92.6% | 0.00% | -90.9% |
| Q1 2014 | $2,569,000 | +220.7% | 19,491 | +185.6% | 0.01% | +266.7% |
| Q4 2013 | $801,000 | -17.2% | 6,825 | -26.3% | 0.00% | 0.0% |
| Q3 2013 | $967,000 | -64.0% | 9,266 | -70.3% | 0.00% | -70.0% |
| Q2 2013 | $2,688,000 | – | 31,230 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |